Riot Platforms, Inc. — Director's Dealing 2012

Sep 21, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-09-19

Reporting Person: Hurd Donald R (SVP, Chief Commerical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-19	Stock Option (Right to Buy)	$2.05	A	10000	Acquired	2022-09-19	Common Stock (10000)	Direct

Footnotes

F1: The option to purchase 10,000 shares of common stock shall become exercisable as to 5,000 of the shares on March 19, 2013, as to 833 of the shares on each of April 19, 2013, May 19, 2013, June 13, 2013 and July 13, 2013, and as to 834 of the shares on each of August 19, 2013 and September 19, 2013.